Ontology highlight
ABSTRACT:
SUBMITTER: Cooper CJ
PROVIDER: S-EPMC6027540 | biostudies-other | 2018 Apr
REPOSITORIES: biostudies-other
Cooper Callum J CJ Koonjan Shazeeda S Nilsson Anders S AS
Pharmaceuticals (Basel, Switzerland) 20180419 2
The resurgence of research into phage biology and therapy is, in part, due to the increasing need for novel agents to treat multidrug-resistant infections. Despite a long clinical history in Eastern Europe and initial success within the food industry, commercialized phage products have yet to enter other sectors. This relative lack of success is, in part, due to the inherent biological limitations of whole phages. These include (but are not limited to) reaching target sites at sufficiently high ...[more]